Bortezomib has anti-proliferative and apoptotic effects against CML stem cells, including the quiescent population

N. Heaney, F. Pellicano, Lisa Crawford, Alexandra Irvine, T.L. Holyoake

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)865A-865A
JournalBlood
Volume110
Publication statusPublished - Dec 2007

Cite this